A new vaccine against typhoid has been proven to be safe and effective in preventing the disease, and can be used to protect both adults and children.
A study published in the Lancet is the first clinical trial to show that immunisation with the typhoid conjugate vaccine (TCV) or Typbar-TCV is safe, well tolerated and will have significant impact on disease incidence in endemic areas that introduce it.
...
AllAfrica Subscription Content
You must be an allAfrica.com subscriber for full access to certain content.
You have selected an article from the AllAfrica archive, which requires a subscription. You can subscribe by visiting our subscription page. Or for more information about becoming a subscriber, you can read our subscription and contribution overview.
For information about our premium subscription services:
You can also freely access - without a subscription - hundreds of today's top Africa stories and thousands of recent news articles from our home page »
Already a subscriber? Sign in for full access to article